Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis

BACKGROUND: Recent studies have shown increased risks of late target lesion failure (TLF) and thrombosis using a bioresorbable scaffold (BRS). However, the results of the ABSORB China study offered a different means of understanding the long-term performance of BRSs. We tested the 3-year clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yizhe, Yao, Zhifeng, Yin, Jiasheng, Chen, Jiahui, Qian, Juying, Shen, Li, Ge, Lei, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729338/
https://www.ncbi.nlm.nih.gov/pubmed/33313234
http://dx.doi.org/10.21037/atm-20-6739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729338/
https://www.ncbi.nlm.nih.gov/pubmed/33313234
http://dx.doi.org/10.21037/atm-20-6739

Ejemplares similares